Studien
Laufende Phase-3-Studien aus ClinicalTrials.gov für die beobachteten Unternehmen. Die Einordnung der Redaktion erscheint erst nach Freigabe.
Zuletzt aktualisierte Profile
14. November 2026
13. November 2026
12. November 2026
11. November 2026
Phase-3-Studien
| Substanz | Unternehmen | Indikation | Status | Register |
|---|---|---|---|---|
| 100mg Eluxadoline | Abbvie | Irritable Bowel Syndrome | Rekrutiert | NCT04880876 |
| 20vPnC | Pfizer | Pneumococcal Diseases | Rekrutiert | NCT07754539 |
| 25mg Eluxadoline | Abbvie | Irritable Bowel Syndrome | Rekrutiert | NCT04880876 |
| AAA617 | Novartis | Oligometastatic Prostate Cancer (OMPC) | Rekrutiert | NCT05939414 |
| AAA817 | Novartis | Prostate Cancer | Rekrutiert | NCT06780670 |
| ABBV-1480 | Abbvie | Non-Small Cell Lung Cancer | Rekrutiert | NCT07756645 |
| ABBV-706 | Abbvie | Small Cell Lung Cancer | Rekrutiert | NCT07365241 |
| Abiraterone acetate | Amgen | Metastatic Castration-resistant Prostate Cancer | Rekrutiert | NCT07213674 |
| ABP938 8 mg | Amgen | Neovascular Age-related Macular Degeneration, nAMD | Rekrutiert | NCT07614776 |
| Abrocitinib | Pfizer | Atopic Dermatitis | Rekrutiert | NCT06807281 |
| Actinium zadavotide guraxetan | AstraZeneca | Metastatic Castration-resistant Prostate Cancer | Rekrutiert | NCT07611110 |
| ADVATE | Takeda | Von Willebrand Disease (VWD) | Rekrutiert | NCT07129343 |
| Afimkibart | Roche | Moderately to Severely Active Crohns Disease | Rekrutiert | NCT06819878 |
| Alogliptin | Celltrion | T2DM, Diabete Type 2 | Rekrutiert | NCT07093476 |
| Alpelisib | Novartis | Lymphatic Malformations | Rekrutiert | NCT05948943 |
| Amivantamab | Janssen-Cilag | Colorectal Neoplasms | Rekrutiert | NCT06750094 |
| Amrubicin | Gilead Sciences | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Rekrutiert | NCT06801834 |
| Anifrolumab | AstraZeneca | Systemic Lupus Erythematosus | Rekrutiert | NCT07430306 |
| Antithrombin concentrate | Sanofi | Hemophilia | Rekrutiert | NCT07285460 |
| Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free | Alcon | Ocular Hyperemia | Rekrutiert | NCT07531043 |
| Apremilast | Amgen | Active Juvenile Psoriatic Arthritis | Rekrutiert | NCT04804553 |
| ARPI | Novartis | Prostate Cancer | Rekrutiert | NCT06855277 |
| ASP2138 | Astellas | Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma | Rekrutiert | NCT07673887 |
| Atezolizumab | Roche | Cancer | Rekrutiert | NCT05862285 |
| Avtozma | MSD | B-cell Acute Lymphoblastic Leukemia | Rekrutiert | NCT07570173 |
| Azacitidine | Janssen-Cilag | Leukemia, Myeloid, Acute | Rekrutiert | NCT06852222 |
| AZD0120 | AstraZeneca | Newly Diagnosed Multiple Myeloma (NDMM) | Rekrutiert | NCT07735637 |
| AZD0486 | AstraZeneca | Large B-cell Lymphoma | Rekrutiert | NCT07215585 |
| Azithromycin | Sanofi | Lung Transplant Rejection | Rekrutiert | NCT06082037 |
| Baloxavir marboxil | Roche | Influenza, Human, Respiratory Tract Infections | Rekrutiert | NCT07827599 |
| Baricitinib | Eli Lilly | Diabetes Mellitus, Type 1 | Rekrutiert | NCT07222332 |
| BE1116 | CSL Behring | Complex Cardiovascular Surgery With Cardiopulmonary Bypass | Rekrutiert | NCT07094087 |
| Bedaquiline | Otsuka | Rifampicin-Resistant Pulmonary Tuberculosis, Multidrug-Resistant Pulmonary Tuberculosis | Rekrutiert | NCT07209761 |
| Belantamab mafodotin | GlaxoSmithKline | Multiple Myeloma, Newly Diagnosed Multiple Myeloma | Rekrutiert | NCT06679101 |
| Belatacept | Bristol-Myers Squibb | Renal Allograft Recipients | Rekrutiert | NCT04877288 |
| Belimumab | GlaxoSmithKline | Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic | Rekrutiert | NCT05878717 |
| Belumosudil | Sanofi | Chronic Graft Versus Host Disease | Rekrutiert | NCT07771439 |
| Belzutifan | MSD | Carcinoma, Renal Cell | Rekrutiert | NCT07489495 |
| Bendamustine | MSD | DLBCL, Diffuse Large B-Cell Lymphoma | Rekrutiert | NCT05139017 |
| Berobenatide | Pfizer | Obesity | Rekrutiert | NCT07794774 |
| Best Available Treatment | Incyte Biosciences | Essential Thrombocythemia | Rekrutiert | NCT07623200 |
| Bevacizumab | Roche | Cancer | Rekrutiert | NCT05862285 |
| Bevacizumab | Merck KGaA | Metastatic Colorectal Cancer | Rekrutiert | NCT07549412 |
| Bevacizumab | Incyte Biosciences | CRC (Colorectal Cancer) | Rekrutiert | NCT07284849 |
| Bevacizumab | MSD | Ovarian Cancer, Peritoneal Cancer | Rekrutiert | NCT07743164 |
| Bevacizumab | Daiichi Sankyo | Ovarian Cancer | Rekrutiert | NCT06819007 |
| Bevacizumab | Eli Lilly | Ovarian Neoplasms, Fallopian Tube Neoplasms | Rekrutiert | NCT07213804 |
| Bevacizumab | GlaxoSmithKline | Ovarian Neoplasms | Rekrutiert | NCT07694427 |
| BGB-43395 | BeiGene | HR+/HER2- Breast Cancer | Rekrutiert | NCT07492641 |
| BGB-B2033 | BeiGene | Hepatocellular Carcinoma, Liver Cancer | Rekrutiert | NCT07836530 |
| BIIB059 | Biogen | Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus | Rekrutiert | NCT06044337 |
| Bimekizumab | UCB | Palmoplantar Pustulosis | Rekrutiert | NCT07219420 |
| Bleximenib | Janssen-Cilag | Leukemia, Myeloid, Acute | Rekrutiert | NCT06852222 |
| BLU-5937 | GlaxoSmithKline | Refractory Chronic Cough | Rekrutiert | NCT07650084 |
| BMS-986393 | Bristol-Myers Squibb | Relapsed or Refractory Multiple Myeloma (RRMM) | Rekrutiert | NCT06615479 |
| BMS-986489 | Bristol-Myers Squibb | Extensive-Stage Small Cell Lung Cancer | Rekrutiert | NCT06646276 |
| BMS-986504 | Bristol-Myers Squibb | Metastatic Non-small Cell Lung Cancer With MTAP Deletion | Rekrutiert | NCT07063745 |
| BNT162b2 | BioNTech | COVID-19 Vaccines | Rekrutiert | NCT07798648 |
| BNT323 | BioNTech | Endometrial Cancer | Rekrutiert | NCT06340568 |
| BNT324 | BioNTech | Metastatic Castration-resistant Prostate Cancer | Rekrutiert | NCT07365995 |
| Brenipatide | Eli Lilly | Depressive Disorder, Major | Rekrutiert | NCT07775300 |
| Brivaracetam | UCB | Epilepsy | Rekrutiert | NCT04715646 |
| C.difficile | Pfizer | Clostridoides Difficile Associated Disease | Rekrutiert | NCT07282665 |
| Cagrilintide | Novo Nordisk, der dänische Diabetes-Pionier | Overweight, Obesity | Rekrutiert | NCT07253285 |
| CagriSema | Novo Nordisk, der dänische Diabetes-Pionier | Diabetes Mellitus, Type 2 | Rekrutiert | NCT07817251 |
| Cariprazine | Gedeon Richter | Schizophrenia | Rekrutiert | NCT03817502 |
| Centanafadine XR | Otsuka | Attention-deficit/Hyperactivity Disorder, Emotional Dysregulation | Rekrutiert | NCT07759154 |
| Cetrorelix acetate | Merck KGaA | Infertility | Rekrutiert | NCT07340827 |
| Cetuximab | Johnson & Johnson | Carcinoma, Squamous Cell | Rekrutiert | NCT04892173 |
| Chemotherapy | Daiichi Sankyo | Gastric Cancer, Gastroesophageal Junction Cancer | Rekrutiert | NCT06731478 |
| Cladribine High Dose | Merck KGaA | Generalized Myasthenia Gravis | Rekrutiert | NCT06463587 |
| Cladribine Low Dose | Merck KGaA | Generalized Myasthenia Gravis | Rekrutiert | NCT06463587 |
| Clotting factor concentrates or bypassing agents | Sanofi | Hemophilia | Rekrutiert | NCT07285460 |
| Concomitant Antibiotic Therapy | Takeda | Pouchitis | Rekrutiert | NCT06443502 |
| Corabotase | Ipsen | Moderate to Severe Glabellar Lines | Rekrutiert | NCT07779252 |
| Corticosteroids | Incyte Biosciences | Chronic Graft-versus-host-disease | Rekrutiert | NCT06585774 |
| CSL300 | CSL Behring | End Stage Kidney Disease | Rekrutiert | NCT05485961 |
| CSL511 Fibrinogen concentrate | CSL Behring | Acquired Fibrinogen Deficiency | Rekrutiert | NCT06617897 |
| CT-P53 | Celltrion | Relapsing-remitting Multiple Sclerosis | Rekrutiert | NCT05906992 |
| CTX001 | Vertex Pharmaceuticals | Beta-Thalassemia, Thalassemia | Rekrutiert | NCT04208529 |
| Dapirolizumab pegol | UCB | Systemic Lupus Erythematosus | Rekrutiert | NCT04976322 |
| Daratumumab | Janssen-Cilag | Multiple Myeloma | Rekrutiert | NCT05552222 |
| Dato-DXd | Daiichi Sankyo | Urothelial Cancer, Bladder Cancer | Rekrutiert | NCT07129993 |
| Dazodalibep | Amgen | Sjögren's Syndrome | Rekrutiert | NCT06747949 |
| Denecimig | Novo Nordisk, der dänische Diabetes-Pionier | Haemophilia A | Rekrutiert | NCT07830732 |
| Donanemab | Eli Lilly | Alzheimer Disease, Dementia | Rekrutiert | NCT07602582 |
| DZP | UCB | Systemic Lupus Erythematosus | Rekrutiert | NCT06617325 |
| EB-1020 164.4 mg | Otsuka | Attention Deficit Hyperactivity Disorder (ADHD) | Rekrutiert | NCT06931080 |
| EB-1020 328.8 mg | Otsuka | Attention Deficit Hyperactivity Disorder (ADHD) | Rekrutiert | NCT06931080 |
| Elafibranor | Ipsen | Primary Biliary Cholangitis (PBC) | Rekrutiert | NCT06016842 |
| Elritercept | Takeda | Myelodysplastic Syndromes | Rekrutiert | NCT06499285 |
| empagliflozin | Celltrion | T2DM, Diabete Type 2 | Rekrutiert | NCT07093476 |
| Endocrine Therapy | Daiichi Sankyo | Advanced Breast Cancer, Metastatic Breast Cancer | Rekrutiert | NCT07683754 |
| Enfortumab vedotin | Astellas | Urothelial Cancer, Urinary Bladder Neoplasms | Rekrutiert | NCT07566156 |
| Eptinezumab | Lundbeck | Episodic Migraine | Rekrutiert | NCT05897320 |
| Etavopivat | Novo Nordisk, der dänische Diabetes-Pionier | Sickle Cell Disease | Rekrutiert | NCT06612268 |
| Fazirsiran Injection | Takeda | Alpha1-Antitrypsin Deficiency | Rekrutiert | NCT06165341 |
| Felzartamab | Biogen | Primary Membranous Nephropathy | Rekrutiert | NCT06962800 |
| Fezolinetant | Astellas | Hot Flashes | Rekrutiert | NCT07829653 |
| Finerenone | Bayer AG | Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric) | Rekrutiert | NCT07188805 |
| FOLFOX | Incyte Biosciences | CRC (Colorectal Cancer) | Rekrutiert | NCT07284849 |
| GS-3242 Injection | Gilead Sciences | HIV-1-infection | Rekrutiert | NCT07708727 |
| GS-3242 Tablet | Gilead Sciences | HIV-1-infection | Rekrutiert | NCT07708727 |
| IgPro20 | CSL Behring | Secondary Immune Deficiency | Rekrutiert | NCT07648264 |
| JNJ-90301900 | Johnson & Johnson | Carcinoma, Squamous Cell | Rekrutiert | NCT04892173 |
| Lebrikizumab | Almirall | Nummular Eczema | Rekrutiert | NCT07542483 |
| Lenacapavir | Gilead Sciences | HIV-1-infection | Rekrutiert | NCT07683000 |
| levoleucovorin | Seattle Genetics | Colorectal Neoplasms | Rekrutiert | NCT05253651 |
| liposomal irinotecan | Astellas | Pancreatic Cancer, Metastatic Pancreatic Cancer | Rekrutiert | NCT07409272 |
| Litifilimab | Biogen | Systemic Lupus Erythematosus (SLE) | Rekrutiert | NCT05352919 |
| Metformin | Celltrion | T2DM, Diabete Type 2 | Rekrutiert | NCT07093476 |
| NBI-1065845 | Neurocrine Biosciences | Major Depressive Disorder | Rekrutiert | NCT06786624 |
| NBI-1117568 | Neurocrine Biosciences | Schizophrenia | Rekrutiert | NCT07105098 |
| Nucresiran | Alnylam Pharmaceuticals | Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, hATTR-PN | Rekrutiert | NCT07223203 |
| Obinutuzumab | BeiGene | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Rekrutiert | NCT06943872 |
| Osavampator | Neurocrine Biosciences | Major Depressive Disorder | Rekrutiert | NCT07196501 |
| Pegcetacoplan | Swedish Orphan Biovitrum | C3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Recurrent Glomerular Disease After Kidney Transplantation | Rekrutiert | NCT07898774 |
| Pembrolizumab | Novocure | Metastatic Non-small Cell Lung Cancer | Rekrutiert | NCT06216301 |
| Platinum based chemotherapy | Novocure | Metastatic Non-small Cell Lung Cancer | Rekrutiert | NCT06216301 |
| Povetacicept | Vertex Pharmaceuticals | Immunoglobulin A Nephropathy | Rekrutiert | NCT07807995 |
| Pumitamig | BioNTech | Breast Neoplasms | Rekrutiert | NCT07173751 |
| Rituximab | BeiGene | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Rekrutiert | NCT06943872 |
| Salanersen | Biogen | Muscular Atrophy, Spinal | Rekrutiert | NCT07444450 |
| Sevabertinib | Bayer AG | Advanced Non-small Cell Lung Cancer, HER2 Mutation | Rekrutiert | NCT06452277 |
| SGT-003 | Solid Biosciences | Duchenne Muscular Dystrophy | Rekrutiert | NCT07160634 |
| STN1013800 eye drops in single dose containers | Santen | Acquired Blepharophimosis | Rekrutiert | NCT06514612 |
| STN1013800 ophthalmic solution | Santen | Blepharoptosis | Rekrutiert | NCT06683651 |
| Suzetrigine | Vertex Pharmaceuticals | Diabetic Peripheral Neuropathic Pain | Rekrutiert | NCT07231419 |
| trastuzumab | Seattle Genetics | Colorectal Neoplasms | Rekrutiert | NCT05253651 |
| tucatinib | Seattle Genetics | Colorectal Neoplasms | Rekrutiert | NCT05253651 |
| Valbenazine | Neurocrine Biosciences | Chorea, Huntington | Rekrutiert | NCT06312189 |
| VNZ | Vertex Pharmaceuticals | Cystic Fibrosis | Rekrutiert | NCT05844449 |
| Vutrisiran | Alnylam Pharmaceuticals | Transthyretin Amyloidosis (ATTR) With Cardiomyopathy | Rekrutiert | NCT06679946 |
| Zilebesiran | Alnylam Pharmaceuticals | High Risk Cardiovascular Disease, Hypertension | Rekrutiert | NCT07181109 |
| Amlenetug | Lundbeck | Multiple System Atrophy | Laufend | NCT06706622 |
| Anakinra | Swedish Orphan Biovitrum | Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset | Laufend | NCT05814159 |
| Avexitide | Amylyx Pharmaceuticals | Post Bariatric Hypoglycemia | Laufend | NCT06747468 |
| BAY3723113 | Bayer AG | Obstructive Hypertrophic Cardiomyopathy | Laufend | NCT07023341 |
| Botulinum toxin type A | Ipsen | Episodic Migraine | Laufend | NCT06047457 |
| Brentuximab vedotin | Seattle Genetics | Diffuse Large B-cell Lymphoma | Laufend | NCT04404283 |
| Darolutamide | Bayer AG | Cancer | Laufend | NCT04464226 |
| DE-117B Eye Drops | Santen | Open Angle Glaucoma, Ocular Hypertension | Laufend | NCT06666855 |
| Efanesoctocog alfa | Swedish Orphan Biovitrum | Haemophilia A (Moderate or Severe) | Laufend | NCT06716814 |
| Elafibranor80mg | Ipsen | Primary Biliary Cirrhosis | Laufend | NCT04526665 |
| KK8398 | Kyowa Kirin | Achondroplasia | Laufend | NCT06926491 |
| Loncastuximab Tesirine | ADC Therapeutics | Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Laufend | NCT04384484 |
| mRNA-1018-H5 | Moderna | Influenza | Laufend | NCT07496450 |
| mRNA-1403 | Moderna | Acute Gastroenteritis, Norovirus Acute Gastroenteritis | Laufend | NCT06592794 |
| Pacritinib | Swedish Orphan Biovitrum | Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis | Laufend | NCT03165734 |
| Rituximab | ADC Therapeutics | Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Laufend | NCT04384484 |
| Tapinarof cream, 1% | Organon | Atopic Dermatitis | Laufend | NCT07265479 |
| Temozolomide | Novocure | Glioblastoma | Laufend | NCT06556563 |
| TEV-56248 | Teva | Asthma | Laufend | NCT06052267 |
| TEV-53408 Dose A | Teva | Vitiligo | Noch nicht begonnen | NCT07920211 |
| TEV-53408 Dose B | Teva | Vitiligo | Noch nicht begonnen | NCT07920211 |
Das ist die Registersicht, nicht die Pipeline der Unternehmen. Je Unternehmen stehen hier bis zu vier Phase-3-Substanzen, auf dem Steckbrief bis zu zwölf. Präklinik steht im Register nicht.